Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging (PETREVASC)
A Prospective, Randomized Trial of Early Revascularization in Stable Ischemic Heart Disease Guided by Positron Emission Tomography of Artery Specific Integrated Comprehensive Quantitative Myocardial Perfusion
Sponsor: The University of Texas Health Science Center, Houston
Terminated
Terminated prematurely due to closure of the PET imaging facility
Other terminated trials from The University of Texas Health Science Center, Houston
- Infantile Hemangioma · Phase PHASE4 · Jul 2025
- Smoking Cessation · Phase PHASE1 · Dec 2024
- Cluster Headache · Phase NA · May 2024
- Methamphetamine Use Disorder · Phase PHASE2 · Mar 2024
- Effect of Methadone on the Duration on Mechanical Ventilation · Phase PHASE4 · Feb 2024
See all terminations from The University of Texas Health Science Center, Houston
Other Ischemic Heart Disease trials with similar outcome
This NA trial investigates Ischemic Heart Disease and is currently terminated or withdrawn. The University of Texas Health Science Center, Houston leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Nov 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2021 — Dec 2022 [monthly]
Recruiting NA
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center, Houston
For direct contact, visit the study record on ClinicalTrials.gov .